Getting access to data in a correct and swift way can be challenging. Deciding to perform a registry study often starts with finding out what variables to ask for, the number of patients and how difficult it will be to access.
We help pharma companies in all sizes and in all areas with a first scan of Swedish and Scandinavian feasibility for a registry study. Some registries are accessible without ethical approval to get group level data. For a more in-depth data collection on patient level, an ethical application is sent in and must be approved to access data.
We can support you all the way to find the best road ahead, whether it is a brief of a treatment pattern or it iss an academic research project with impact potential.
Often you need to make use of more than one registry to find what you need. We provide all the knowledge and technology to combine multiple data sources without getting lost.
Through our collaboration with Halmstad University, we have a unique possibility to access more than 50 databases of patient data, all linked together.
The master database integrates all data from a part of all publicly funded healthcare since 2012 including;